Trusted Resources: Education
Scientific literature and patient education texts
Early and Late Brain Resonance Findings of Two Siblings With Hunter Syndrome
source: Revista de Neurologia
year: 2021
authors: Silvestre-Avendaño JJ,Morales-Vásquez DE,Muñoz-Zuñiga JR
summary/abstract:Mucopolysaccharidosis type II (MPS II) is a lysosomal disease caused by deficiency of the enzyme iduronate-2-sulfatase (IDS), linked to the X chromosome, producing a wide spectrum of clinical manifestations.
organization: Universidad Nacional de Colombia, Bogotá DC, Colombia.DOI: 10.33588/rn.7301.2021203
read more
BookmarkRelated Content
-
Mucopolysaccharidoses Type I Gene TherapyMucopolysaccharidoses type I (MPS I) is ...
-
International MPS NetworkCreated in April 1992 by Christine Laver...
-
Single Screening of Newborns for 8 Lysosomal Storage Diseases, Including MPS, PossibleResearchers have developed an efficient ...
-
Oxidative Stress in Mucopolysaccharidoses: Pharmacological ImplicationsAlthough mucopolysaccharidoses (MPS) are...
-
Mount Sinai – Lysosomal Storage Disease ProgramThe Mount Sinai Hospital’s Lysosomal S...
-
Emotional Responses to Diagnosis of MPS or MLIf you or someone you know have been dia...
-
Mucopolysaccharidosis (MPS)https://slideplayer.com/slide/17257432/...
Powered by
